Insiders / Davis Matthew W.

Davis Matthew W.

CIK 2094283personinsider

Companies

First seen

Mar 11, 2026

Last activity

Mar 11, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
Aquestive Therapeutics, Inc. · AQST	Executive	100,000	100,000	2	—

2 positions · latest reported per filing

Company	Security	Shares	As of
Aquestive Therapeutics, Inc.	Common Stock	100,000	Mar 9, 2026
Aquestive Therapeutics, Inc.	Non-Qualified Stock Option (right to buy)Derivative	50,000	Mar 9, 2026

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Mar 9, 2026	Grant	AQST Aquestive Therapeutics, Inc. Common Stock	$0	+50K +100.00%	100,000 0.08% of shares	low
Mar 9, 2026	Grant	AQST Aquestive Therapeutics, Inc. Non-Qualified Stock Option (right to buy)	—	+50K	50,000 0.04% of shares	low